CONTENTS
· Scientific Agenda
· Continuing Medical Education
· Who Should Attend?
· Educational Objectives
· Registration
· Satellite Organizer

CORPORATE SUPPORT
This dinner satellite is made possible by an unrestricted educational grant from:.

 

 

 

 

 

    
Email this link to a friend Print this page

DECEMBER 15, 2007
Integrating Novel Targeted Therapies into Management of Advanced Breast Cancer
A Dinner Satellite at the 30th Annual San Antonio Breast Cancer Symposium (SABCS)
7:30 pm – 10:00 pm
Hyatt Regency – Ballroom Regency East
San Antonio, Texas

Chair
Ruth O’Regan, MD
Emory University
Winship Cancer Institute
Atlanta, Georgia

Click here to register online.
  S C I E N T I F I C   A G E N D A

Saturday, December 15, 2007

7:30 pm
Dinner

8:00 pm
Welcome

8:05 pm
An overview on the mechanisms and characteristics of novel targeted agents in development for advanced breast cancer
Kimberly Blackwell, MD
Duke University Medical Center
Durham, North Carolina

8:30 pm
Emerging targeted therapies for advanced hormone receptor positive breast cancer
Ruth O’Regan, MD
Emory University
Winship Cancer Institute
Atlanta, Georgia

8:50 pm
Ongoing and planned clinical trials in anti-angiogenic therapy for advanced breast cancer
Mark Pegram, MD
University of Miami
Miami, Florida

9:15 pm
Integrating novel targeted agents into established therapeutic regimens for advanced breast cancer
Hope Rugo, MD
University of California
San Francisco Comprehensive
Cancer Center
San Francisco, California

9:40 pm
Panel discussion on the integration of novel targeted agents into breast cancer therapeutic platforms

10:00 pm
Adjourn

.
  C O N T I N U I N G  M E D I C A L  E D U C A T I O N .

.

Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Imedex, LLC designates this educational activity for a maximum 2.0 of AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
.
  W H O   S H O U L D   A T T E N D ? .

This educational activity is specifically designed for oncologists, internists, and other physicians, physicians-in-training, and healthcare professionals (nurses, pharmacists) involved in and/or interested in breast cancer. No specialized knowledge or skill other than general familiarity with oncology or internal medicine is required for successful participation.
.
  E D U C A T I O N A L  O B J E C T I V E S .

After successful completion of this program, the participant will be able to:

  • Discuss targeted therapies which are in development for advanced breast cancer
  • Identify and discuss emerging targeted therapies for advanced hormone receptor positive breast cancer
  • Compare and contrast various clinical trials which involve the utilization of anti-angiogenic therapy for advanced breast cancer
  • Discuss the incorporation of targeted agents into established therapeutic regimens for advanced breast cancer

  R E G I S T R A T I O N

This is a complimentary educational program and space is limited. To confirm your attendance, please register by December 6, 2007.

Click here to register.

  S A T E L L I T E  O R G A N I Z E R


          4325 Alexander Drive
          Alpharetta, GA 30022-3740 USA
          Tel.: +1 (770) 751 7332
          Fax: +1 (770) 751 7334
          Email: meetings@imedex.com
          Web: www.imedex.com

 

© 2007 Imedex®, LLC

 
 
  Imedex, LLC
  Tel. +1 (770) 751-7332
  Fax +1 (770) 751-7334

  © 2007 Imedex, LLC
  All rights reserved.